The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.

Getty Images


September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.

Interventional oncology is a fast-growing offshoot of interventional radiology in which treatment is applied directly to the tumor through a catheter. Compared with conventional treatments like surgery and chemotherapy, these minimally invasive image-guided procedures have lower complication rates, superior toxicity profiles and often comparable or superior outcomes—so much so that international guidelines have already adopted thermal ablation, or the destruction of tumors through heat, as a first-line treatment option for certain smaller-sized malignant tumors.

Treatment effectiveness is measured through a variety of means such as disease-free and progression-free survival. A lack of consensus regarding these parameters in oncology-related studies and how to uniformly share these outcomes amongst investigators worldwide has created a host of problems. Issues like different complication-related outcomes reported for the same treatment modality and inconsistencies in the reporting of overall survival data means that study results cannot always be reliably compared.

“Study results are being collected, analyzed and reported in many different ways, and we tend not to speak the same language within the field of clinical oncology,” said study lead author Robbert S. Puijk, M.D., a radiology resident and researcher at the Onze Lieve Vrouwe Gasthuis Hospital and Amsterdam University Medical Centers in Amsterdam.

To address these shortcomings, an international panel of 62 experts recently convened and developed important recommendations on how to uniformly collect, analyze and report outcomes for patients treated with image-guided tumor ablation.

Among key recommendations, the panel determined that, to compare different treatment techniques, outcomes should be analyzed and reported per patient and per tumor. This is because multiple index tumors within one unique patient, such as multiple liver metastases from colorectal cancer, are often treated simultaneously and cannot be regarded as independent.

The panel agreed that parameters like overall survival and disease-free survival should be analyzed per patient and not on a per tumor or per procedure basis. Parameters that address both procedure-related side-effects and direct costs such as short-term complications and anesthesia techniques should be addressed per procedure, the panelists concluded.

The panelists reached several other important agreements, including ones regarding the definitions for recurrence-free, disease-free and progression-free survival.

The new guidelines will boost interventional oncology in a variety of ways, according to Puijk.

“The given definitions in these current guidelines will provide the necessary foundation for scientific reproducibility between interventional oncology studies as they will ensure an objective and reliable interpretation of study outcomes, allow for accurate comparisons of results and avoid misinterpretations,” he said.

Puijk called the participation of a large number of international experts on the panel a key motivating factor to putting the guidelines on paper.

“Together with the help of independent biostatisticians and epidemiologists, it strengthens our methodology and indicates the importance of this project,” he said. “Widespread adoption of these guidelines is another step forward in the professionalization of our field, interventional oncology.” 

The researchers hope to extend these guidelines to regional and systemic cancer treatments and ultimately attract the participation of other medical societies.

“With this interchangeable setup and a similar study design we intend to follow up this project regularly,” Puijk said.

The project represented a collaboration between the Society of Interventional Oncology (SIO) and the Definition for the Assessment of Time-to-event Endpoints in Cancer (DATECAN) trials initiative. Puijk’s colleague, Martijn R. Meijerink, M.D., Ph.D., was senior author on the paper.

For more information: www.radiologyinfo.org


Related Content

News | Radiation Therapy

May 30, 2023 — The first treatment, for a patient with prostate cancer, was successfully carried out on April 28. Yonsei ...

Time May 30, 2023
arrow
News | Pediatric Imaging

May 24, 2023 — A new advanced form of computed tomography (CT) imaging called photon-counting computed tomography (PCCT) ...

Time May 24, 2023
arrow
News | Oncology Information Management Systems (OIMS)

May 24, 2023 — RaySearch Laboratories AB announced that the oncology information system RayCare* (* subject to ...

Time May 24, 2023
arrow
News | ASTRO

May 23, 2023 — More than 9 in 10 radiation oncologists report that their practices face clinical staff shortages ...

Time May 23, 2023
arrow
News | Radiation Oncology

May 23, 2023 — ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that ...

Time May 23, 2023
arrow
News | Radiation Oncology

May 22, 2023 — Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center will discuss the latest ...

Time May 22, 2023
arrow
News | Mammography

May 22, 2023 — Incorrect advice by an AI-based decision support system could seriously impair the performance of ...

Time May 22, 2023
arrow
News | PET Imaging

May 22, 2023 — New research finds that the brains of otherwise healthy military personnel who are exposed to explosions ...

Time May 22, 2023
arrow
News | Radiology Imaging

May 19, 2023 — Asymptomatic adults with a high accumulation of fat in their muscles, known as myosteatosis, are at an ...

Time May 19, 2023
arrow
News | Artificial Intelligence

May 19, 2023 — The latest version of ChatGPT passed a radiology board-style exam, highlighting the potential of large ...

Time May 19, 2023
arrow
Subscribe Now